AFRICAN MALARIA NETWORK TRUST

CLOSED

Tanzania Commission For Science And Technology Building, Dar Es Salaam, Tanzaniawww.amanet-trust.orgPrivateEstablished: 2002-01-01

Also known as:

amanet

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2002

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

83.3%

Phase 2

16.7%

Trial Status Distribution

Unknown

100.0%

Clinical Trials

Trials sponsored by this organization (6)

Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years

Phase 1

Unknown

interventional

Jun 200830 participants

Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine

Phase 2

Unknown

interventional

May 2008378 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations

AFRICAN MALARIA NETWORK TRUST

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (6)

Safety and Immunogenicity of 30 and 100 µg of GMZ2 in Gabonese Children Aged 1-5 Years

Immunogenicity, Efficacy and Safety Study of an MSP3-LSP (Long Synthetic Peptide) Malaria Vaccine

Phase Ib Trial of MSP3 LSP in Children in Tanzania

Safety of Recombinant Hybrid GMZ 2 [GLURP + MSP 3] Blood Stage Malaria Vaccine

Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])

A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso

Approvals

News